Perioperative and early postoperative results of photoselective vaporisation of the prostate using fiber 4090 (providing 120 watts) versus fiber MOXY (providing 180 watts);Résultats périopératoires et postopératoires précoces de la photovaporisation prostatique au laser Greenlight XPS selon l'utilisation d'une fibre 4090 délivrant 120 watts ou d'une fibre MOXY délivrant 18

Progres en Urologie

Volumn 22, Issue 9, 2012, Pages 529-533

  Tanchoux, C ^a   Pereira, H ^a   Brichart, N ^a   Bruyere F ^a  

^a CHU BRETONNEAU   (France)

Author keywords

Fiber; HBP; Photovaporisation; Power

Indexed keywords

AGED; ARTICLE; BLADDER CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LENGTH OF STAY; LOW LEVEL LASER THERAPY; MALE; METHODOLOGY; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; STATISTICS; TIME;

AGED; HUMANS; LASER THERAPY; LENGTH OF STAY; MALE; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; TIME FACTORS; URINARY CATHETERIZATION;

EID: 84862771046     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2012.04.012     Document Type: Article

References (9)

1. Nomura H., Seki N., Yamaguchi A., Naito S. Comparison of photoselective vaporization and standard transurethral resection of the prostate on urodynamics in patients with benign prostatic hyperplasia. Int J Urol 2009, 16:657-662.
2. Fourmarier M., Azzouzi A.R., Robert G., Saussine C., Devonec M., Haillot O., et al. Revue de la littérature sur l'utilisation des lasers pour le traitement de l'HBP symptomatique. Prog Urol 2009, 19:153-157.
3. Heinrich E., Wendt-Nordahl G., Honeck P., Alken P., Knoll T., Michel M.S., et al. 120W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80W potassium-titanyl-phosphate laser in an ex vivo model. J Endourol 2010, 24:75-79.
4. Bachmann A., Muir G.H., Collins E.J., Choi B.B., Tabatabataei S., Reich O.M., et al. 180-W XPS Greenlight laser therapy for benign prostate hyperplasia: early safety, efficacy and perioperative outcome after 201 procedures. Eur Urol 2012, 61(3):600-607.
5. Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004, 240:205-213.
6. Tasci A.I., Ilbey Y.O., Luleci H., Cicekler O., Sahin S., Cevik C., et al. 120 watts greenlight laser photoselective vaporization of the prostate for BPH: midterm outcomes. Urology 2011, 78:134-140.
7. Spaliviero M., Araki M., Wong C. Short term outcomes of Greenlight HPS laser PVP for BPH. J Endourol 2008, 22:2341-2347.
8. Gu X., Strom K., Spaliviero M., Wong C. Intermediate outcomes of Greenlight HPS laser PVP prostatectomy for symptomatic BPH. J Endourol 2011, 25:1037-1041.
9. Capitàn C., Blàsquez C., Martin M.D., Hernàndez V., de la Penà E., Llorente C. Greenlight HPS 120W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign hypertrophic prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol 2011, 60:734-739.